期刊文献+

2型糖尿病治疗药物新进展——第45届欧洲糖尿病协会(EASD)年会侧记 被引量:1

下载PDF
导出
摘要 第45届欧洲糖尿病协会(EASD)年会于2009年9月29日-10月2日在奥地利维也纳召开。会议就2型糖尿病药物治疗新进展进行了专题报告,现将研究内容简述如下。
出处 《国际老年医学杂志》 2010年第1期44-45,共2页 International Journal of Geriatrics
  • 相关文献

同被引文献37

  • 1朱翊,傅得兴.二肽基肽酶Ⅳ抑制剂的研究进展[J].中国药学杂志,2007,42(17):1284-1286. 被引量:7
  • 2Salehi M,D'Alessio DA.New therapies for type 2 diabetes basedon glucagon-like 1[J].Cleve Clin J Med,2006,73(4):382-389.
  • 3陈玲,伊力多斯.艾合他木夫.胰高血糖素样肽-1生理作用及其在2型糖尿病中应用[J].中国实用诊断与治疗杂志,2011,25(6):525-527.
  • 4Lam S,See S.Exenatide:a novel incretin mimetic agent for treatingtype 2 diabetes mellitus[J].Cadiol Rev,2006,14(4):205-211.
  • 5Kim D,MacConell L,zhuang D,et al.Effect of once-weekly dosingof a lon-acting release formulation of exenatide on glucose controland body weight in subject with type 2 diabetes[J].DiabetesCare,2007,30(6):1487-1493.
  • 6Garber A,Henry R,Ratner R,et al.Liralutide versus glimepiridemonotherapy for type 2 diabetes(LEAD-3 Mono):a radomised,52-week,phase,III,double-blind,parallel-treatment trial[J].Lancet,2009,373(9662):473-481.
  • 7Jeong KH,Yoo BK.The efficacy and safely of liraglutide[J].Int JClin Pharm,2011,33(5):740-749.
  • 8Repas T.Next-generation GLP-1 therapy:an introduction to liraglu-tide[J].Postgrad Med,2011,123(5):239-247.
  • 9Dharmalingam M,Sriram U,Baruah MP.Liraglutide:A review of itstherapeutic use as a once daily GLP-1 analog for management oftype 2 diabetes mellitus[J].Indian J Endocrinol Metab,2011,15(1):9-17.
  • 10Nauck MA,Ratner RE,Kaptiza C,et al.Treatment with the humanonce-weekly glucagon-like peptide-1 analog taspoglutide in combi-nation with metformin improves glycemic control and lowers bodyweight in patients with type 2 diabetes inadequately controlled withmetformin alone:a double-blind placebo-controlled study[J].Diabetes Care,2009,32(7):1237-1243.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部